Image

PATAKESS Protocol : Clinical and Biological Analysis of Exocrine Pancreatic Tumors

Study on Exocrine Pancreatic Tumors and Their Biological and Clinical Characteristics

Recruiting
18 years and older
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

The purpose of this study is to investigate exocrine pancreatic tumors. This study examines clinical and biological data from patients with exocrine pancreatic tumors to understand more about the condition.

This study evaluates the relationship between biological and clinical characteristics of exocrine pancreatic tumors. It focuses on understanding how these characteristics interact and affect the progression of the condition.

  • Who can participate: Adults 18 years or older who have had surgery for exocrine pancreatic adenocarcinoma at Centre Léon Bérard since January 1, 2010, and have a confirmed histological diagnosis are eligible to participate.
  • Study details: Participants will provide clinical and biological data derived from tumor samples taken during routine healthcare. This data will assist researchers in understanding the characteristics of exocrine pancreatic tumors.
Print
Study details
    Exocrine Pancreatic Cancer

NCT04011982

Centre Leon Berard

31 July 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.